Funding boost from Research England

 

Research England, through the Connecting Capabilities Fund,  has awarded £1.3m to London Advanced Therapies to work with partners across the UK.

Together, we will catalyse the UK capabilities and outputs in the area of Advanced Therapies, through fostering collaborative work, facilitating commercial partnerships and creating a microclimate for innovation.

UK Advanced Therapies

United to accelerate Cell and Gene Based Therapies

 

This is a collaboration between

King’s College London, University College London, Imperial College London, Queen Mary University of London, University of Bristol, The University of Manchester, The University of Sheffield, Newcastle University, University of Birmingham, The University of Edinburgh,  University of Glasgow, Queen’s University Belfast, Ulster University.

MEDcity, Northern Health Science Alliance SULSA, Scottish Enterprises, Health Innovation Research Alliance Northern Ireland.

UKAT